Mani Shanti Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
as on 20-12-2024
- Paid Up Capital ₹ 0.10 M
as on 20-12-2024
- Company Age 3 Year, 7 Months
- Last Filing with ROC 31 Mar 2022
About Mani Shanti Pharmaceuticals
The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Shambhoo Tripathi, Sharad Tripathi, Sangita Tripathi, and One other member serve as directors at the Company.
- CIN/LLPIN
U24239UP2021PTC146190
- Company No.
146190
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
15 May 2021
- Date of AGM
30 Nov 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Company Details
- Location
Gorakhpur, Uttar Pradesh, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Mani Shanti Pharmaceuticals?
Board Members(4)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Shambhoo Tripathi | Director | 15-May-2021 | Current |
Sharad Tripathi | Director | 16-Aug-2022 | Current |
Sangita Tripathi | Director | 15-May-2021 | Current |
Shiv Tripathi | Director | 19-May-2022 | Current |
Financial Performance of Mani Shanti Pharmaceuticals.
Enhance accessibility to Mani Shanti Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue | |||||||
Revenue from Operations | |||||||
Total Assets | |||||||
Profit or Loss | |||||||
Net Worth | |||||||
EBITDA |
What is the Ownership and Shareholding Structure of Mani Shanti Pharmaceuticals?
Unlock access to Mani Shanti Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
- Mani Shanti Infracity Private LimitedActive 14 years 7 months
Shambhoo Tripathi and Sharad Tripathi are mutual person
- Mani Shanti E-Commerce Private LimitedActive 4 years 4 months
Shambhoo Tripathi, Sharad Tripathi and 2 more are mutual person
- Mani Shanti Technology Private LimitedActive 1 year 7 months
Shambhoo Tripathi and Sangita Tripathi are mutual person
- Mani Shanti Infrabuilds Private LimitedActive 2 years 10 months
Shambhoo Tripathi, Sharad Tripathi and 1 more are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Mani Shanti Pharmaceuticals?
Mani Shanti Pharmaceuticals has a workforce of 0 employees as of Mar 29, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Mani Shanti Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Mani Shanti Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.